keyword
https://read.qxmd.com/read/38648979/antibody-drug-conjugates-in-lung-and-breast-cancer-current-evidence-and-future-directions-a-position-statement-from-the-etop-ibcsg-partners-foundation
#21
REVIEW
S Peters, S Loi, F André, S Chandarlapaty, E Felip, S P Finn, P A Jänne, K M Kerr, E Munzone, A Passaro, M Pérol, E F Smit, C Swanton, G Viale, R A Stahel
Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and >100 in clinical development. In lung cancer, trastuzumab deruxtecan (T-DXd) is approved in human epidermal growth factor receptor 2 (HER2)-mutated, unresectable or metastatic non-small cell lung cancer, with ADCs targeting HER3 (patritumab deruxtecan), trophoblast cell-surface antigen 2 (datopotamab deruxtecan and sacituzumab govitecan [SG]) and mesenchymal-epithelial transition factor (telisotuzumab vedotin) in late-stage clinical development...
April 20, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/38647994/current-status-of-partial-laryngeal-surgery-for-advanced-laryngeal-cancer-when-and-why
#22
REVIEW
Erika Crosetti, Marco Fantini, Ilaria Bertotto, Andy Bertolin, Giulia Arrigoni, Andrea Lorenzi, Giovanni Succo
PURPOSE OF REVIEW: This paper aims to evaluate the evolution and current status of partial laryngeal surgery in the treatment of advanced laryngeal cancer (LC). Specifically, recent progress in the selection of both patients and tumors, together with surgical and rehabilitation innovations, have contributed to balancing oncological control with the maintenance of quality of life in naïve and radiorecurrent patients. The main aspect is represented by the recognized role of open partial horizontal laryngectomies (OPHLs) in this new era of laryngeal cancer treatment...
April 22, 2024: Current Oncology Reports
https://read.qxmd.com/read/38647912/laparoscopic-anatomical-cranial-sub-segmentectomy-of-segment-vii-s7-with-super-selective-intra-arterial-nano-icg-positive-staining-guided-trans-parenchymal-approach
#23
JOURNAL ARTICLE
Ziqi Hou, Guoteng Qiu, Qingyun Xie, Jiwei Huang
BACKGROUND: With introduction of "cone unit," which is the smallest resectable anatomical area supplied by a tertiary branch of Glissonean pedicle, more precise subsegmental anatomical resection has been proposed.1 Super-selective intra-arterial ICG staining, delivering ICG and lipiodol mixing to arterial branch using interventional radiology, has been proved feasibility especially for complicated anatomy.2-6 It was difficult to uniformly mix water-soluble ICG with lipophilic lipiodol, rendering to inconsistency development of liver segment between angiography and laparoscopy...
April 22, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38647375/y-chromosome-loss-and-implications-for-oncology
#24
JOURNAL ARTICLE
Canan D Dirican, Peter S Nelson
The Y chromosome has recognized functions in promoting male sex determination and regulating aspects of fertility. However, recent work has demonstrated important roles for the Y chromosome and Y-encoded genes in multiple domains of male health, including cancer. It is well-established that males experience shorter life spans than females, and this sex bias on overall mortality is ac-centuated in populations with longer life expectancy, in part related to elevated rates of cancer. The majority of human malignancies exhibit a sex bias with elevated frequencies in males...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38646501/progress-in-cancer-research-on-the-regulator-of-phagocytosis-cd47-which-determines-the-fate-of-tumor-cells-review
#25
REVIEW
Fan Wu, Hongyuan Pang, Fan Li, Mengqing Hua, Chuanwang Song, Jie Tang
Cluster of differentiation 47 (CD47) is a transmembrane protein that is widely and moderately expressed on the surface of various cells and can have an essential role in mediating cell proliferation, migration, phagocytosis, apoptosis, immune homeostasis and other related responses by binding to its ligands, integrins, thrombospondin-1 and signal regulatory protein α. The poor prognosis of cancer patients is closely associated with high expression of CD47 in glioblastoma, ovarian cancer, breast cancer, bladder cancer, colon cancer and hepatocellular carcinoma...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646500/tumor%C3%A2-suppressive-effects-of-smad%C3%A2-ubiquitination-regulator-2-in-papillary-thyroid-carcinoma
#26
JOURNAL ARTICLE
Guirong Luo, Liting Zhang, Lihong Zhang, Wenyi Wu, Jianqing Lin, Haihong Shi, Yihuang Yu, Weigang Qiu, Jinyan Chen, Hansen Ding, Xinyao Chen
Smad-ubiquitination regulator 2 (SMURF2) functions as a homolog of E6AP carboxyl terminus-type E3 ubiquitin ligase to regulate cell cycle progression and tumor growth factor expression. SMURF2 has been revealed to function as a tumor suppressor in a number of cancers; however, its function in papillary thyroid carcinoma (PTC) remains largely unknown. Therefore, the aim of the present study was to investigate the function of SMURF2 in PTC. Reverse transcription-quantitative PCR and western blotting were used to detect cellular expression of SMURF2 in vitro ...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646493/non%C3%A2-coding-rna-a-promising-diagnostic-biomarker-and-therapeutic-target-for-esophageal-squamous-cell-carcinoma-review
#27
REVIEW
Longze Zhang, Yanyang Wang, Jianmei Gao, Xue Zhou, Minglei Huang, Xianyao Wang, Zhixu He
Esophageal cancer (EC) is a common form of malignant tumor in the digestive system that is classified into two types: Esophageal squamous cell carcinomas (ESCC) and esophageal adenocarcinoma. ESCC is known for its early onset of symptoms, which can be difficult to identify, as well as its rapid progression and tendency to develop drug resistance to chemotherapy and radiotherapy. These factors contribute to the high incidence of disease and low cure rate. Therefore, a diagnostic biomarker and therapeutic target need to be identified for ESCC...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646440/macrophage-colony-stimulating-factor-and-its-role-in-the-tumor-microenvironment-novel-therapeutic-avenues-and-mechanistic-insights
#28
REVIEW
Li Yi, Yihan Gai, Zhuo Chen, Kecan Tian, Pengfei Liu, Hongrui Liang, Xinyu Xu, Qiuyi Peng, Xiaoqing Luo
The tumor microenvironment is a complex ecosystem where various cellular and molecular interactions shape the course of cancer progression. Macrophage colony-stimulating factor (M-CSF) plays a pivotal role in this context. This study delves into the biological properties and functions of M-CSF in regulating tumor-associated macrophages (TAMs) and its role in modulating host immune responses. Through the specific binding to its receptor colony-stimulating factor 1 receptor (CSF-1R), M-CSF orchestrates a cascade of downstream signaling pathways to modulate macrophage activation, polarization, and proliferation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38646439/diversity-of-extracellular-hsp70-in-cancer-advancing-from-a-molecular-biomarker-to-a-novel-therapeutic-target
#29
REVIEW
Binbin Hu, Guihong Liu, Kejia Zhao, Gao Zhang
Heat shock protein 70 (HSP70) is a highly conserved protein functioning as a "molecular chaperone", which is integral to protein folding and maturation. In addition to its high expression within cells upon stressful challenges, HSP70 can be translocated to the cell membrane or released from cells in free form or within extracellular vesicles (EVs). Such trafficking of HSP70 is also present in cancer cells, as HSP70 is overexpressed in various types of patient samples across a range of common malignancies, signifying that extracellular HSP70 (eHSP70) can serve as a tumor biomarker...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38646212/a-review-of-the-efficacy-of-the-low-fermentable-oligosaccharides-disaccharides-monosaccharides-and-polyols-fodmap-diet-in-managing-gastrointestinal-symptoms-related-to-cancer-treatment
#30
REVIEW
Arwa S Almasaudi
The low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet, designed to alleviate symptoms in individuals with irritable bowel syndrome (IBS), focuses on limiting the consumption of poorly absorbed fermentable carbohydrates known as FODMAP. These FODMAP are believed to be the primary triggers for food-related gastrointestinal symptoms in functional gastrointestinal disorders. However, there is currently insufficient direct evidence investigating the role of low FODMAP diets in cancer patients undergoing treatment...
March 2024: Curēus
https://read.qxmd.com/read/38646146/pre-and-post-treatment-quality-of-life-among-patients-with-advanced-stage-cervical-cancer-at-tikur-anbessa-specialized-hospital-ethiopia
#31
JOURNAL ARTICLE
Roza Teshome, Irene Yang, Edom Woldetsadik, Eshetu Girma, Melinda Higgins, Jessica Wells
BACKGROUND: The development of health concepts beyond traditional markers of illness and death has made the evaluation of quality of life (QoL) crucial to patient care. Yet, there is little research evaluating the pre- and post-treatment QoL of cervical cancer survivors in Ethiopia. OBJECTIVE: This study aimed to assess the pre- and post-treatment QoL of women diagnosed with advanced-stage cervical cancer. METHODS AND MATERIALS: A cohort design was conducted at the Tikur Anbessa Specialized Hospital Oncology Center...
2024: Cancer Management and Research
https://read.qxmd.com/read/38645488/hippocampal-subfield-volumetric-changes-after-radiotherapy-for-brain-metastases
#32
JOURNAL ARTICLE
Klara Holikova, Iveta Selingerova, Petr Pospisil, Martin Bulik, Ludmila Hynkova, Ivana Kolouskova, Lucie Hnidakova, Petr Burkon, Marek Slavik, Jiri Sana, Tomas Holecek, Jiri Vanicek, Pavel Slampa, Radim Jancalek, Tomas Kazda
BACKGROUND: Changes in the hippocampus after brain metastases radiotherapy can significantly impact neurocognitive functions. Numerous studies document hippocampal atrophy correlating with the radiation dose. This study aims to elucidate volumetric changes in patients undergoing whole-brain radiotherapy (WBRT) or targeted stereotactic radiotherapy (SRT) and to explore volumetric changes in the individual subregions of the hippocampus. METHOD: Ten patients indicated to WBRT and 18 to SRT underwent brain magnetic resonance before radiotherapy and after 4 months...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38645412/link-a-unveiling-its-functional-role-and-clinical-significance-in-human-tumors
#33
REVIEW
Bing Liao, Jialing Wang, Yilin Xie, Hongliang Luo, Jun Min
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer, ovarian cancer, glioma, non-small-cell lung cancer, and mantle cell lymphoma. Notably, LINK-A is involved in regulating critical cancer-related pathways, such as AKT and HIF1α signaling, and is implicated in a range of oncogenic activities, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), cell invasion and migration, and glycolysis reprogramming...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38644918/-en-bloc-resection-followed-by-gluteal-advancement-flap-for-sacral-ewing-s-sarcoma-a-novel-technique
#34
Jeena Joseph, Krishna Prabhu, Edmond Jonathan, Mark Ranjan Jesudason, Ashish Kumar Gupta
Ewing's sarcoma is a rare and highly aggressive bone tumor primarily affecting children and adolescents. It commonly presents in the pelvic and axial skeleton, with sacral involvement posing unique challenges due to its intricate anatomical location. This report details the case of an 18-year-old male with sacral Ewing's sarcoma, emphasizing the diagnostic, surgical, and reconstructive aspects of management. The patient presented with lower back pain, lower limb weakness, and urinary incontinence, which prompted an extensive diagnostic evaluation...
2024: Journal of Craniovertebral Junction and Spine
https://read.qxmd.com/read/38644759/prevalence-and-impact-of-endocrine-disorders-in-advanced-metastatic-cancer-patients-undergoing-cancer-directed-therapy-a-prospective-observational-study
#35
JOURNAL ARTICLE
Gaurav Karna, Amit Sehrawat, Saurabh Karna, Ravi Kant, Deepak Sundriyal, Summi Karn, Dipesh Jha
BACKGROUND: Noncommunicable diseases (NCDs) contribute significantly to global morbidity and mortality, with cancer being one of the leading causes. In this prospective observational study, we aimed to investigate the prevalence and impact of endocrine disorders, specifically diabetes and thyroid dysfunction, in patients with advanced metastatic cancer undergoing cancer-directed therapy. METHODS: Over 15 months, we recruited 100 histologically proven advanced metastatic cancer patients from the Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, and conducted institutional-based prospective observational study...
April 2024: Cancer reports
https://read.qxmd.com/read/38644691/comprehensive-analysis-of-n6-methylandenosine-related-lncrnas-in-clear-cell-renal-cell-carcinoma-a-correlation-with-prognosis-tumor-progression-and-therapeutic-response
#36
JOURNAL ARTICLE
Chang Meng, Juan Li, Xiang Wang, Yicen Ying, Zhihua Li, Aixiang Wang, Xuesong Li
This study aims to develop a prognostic signature based on m6A-related lncRNAs for clear cell renal cell carcinoma (ccRCC). Differential expression analysis and Pearson correlation analysis were used to identify m6A-related lncRNAs associated with patient outcomes in The Cancer Genome Atlas (TCGA) database. Our approach led to the development of an m6A-related lncRNA risk score (MRLrisk), formulated using six identified lncRNAs: NFE4, AL008729.2, AL139123.1, LINC02154, AC124854.1 and ARHGAP31-AS1. Higher MRLrisk was identified as a risk factor for patients' prognosis in ccRCC...
April 21, 2024: Cancer Investigation
https://read.qxmd.com/read/38644545/stepwise-analysis-of-thyroid-diagnostic-modalities-with-genomic-imprinting-detection
#37
JOURNAL ARTICLE
Wanting Yang, Ming Yin, Jiehong Zhou, Yun Zhu, Beibei Ye, Hui Shi, Bingjie Zhang, Can Yue, Yifeng Zhang, Hongxun Wu, Haohao Li, Xuliang Xia, Shufang Yang, Buyun Ma
BACKGROUND: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)-an adjunctive molecular test based on epigenetic imprinting alterations...
April 12, 2024: Chinese Clinical Oncology
https://read.qxmd.com/read/38644270/-analysis-of-factors-influencing-the-efficacy-and-prognosis-of-surgical-treatment-for-primary-malignant-pelvic-bone-tumors
#38
JOURNAL ARTICLE
W F Liu, L Hao, Z Y Li, T Jin, Y Sun, Y K Yang, Y Li, F J Yang, F Yu, Q Zhang, X H Niu
Objective: To analyze the prognostic factors and the influence of surgical margin to prognosis. Methods: A retrospective analysis was performed for 208 pelvic tumors who received surgical treatment from January 2000 to December 2017 in our instituition. Survival analysis was performed using the Kaplan-Meier method and Log rank test, and impact factor analysis was performed using Cox regression models. Results: There were 183 initial patients and 25 recurrent cases. According to Enneking staging, 110 cases were stage ⅠB and 98 cases were stage ⅡB...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38644266/-chinese-expert-consensus-on-the-management-of-clinical-pathway-and-adverse-events-of-trastuzumab-deruxtecan-2024-edition
#39
JOURNAL ARTICLE
(no author information available yet)
Trastuzumab deruxtecan (T-DXd) is one of the new generation antibody-drug conjugates (ADCs) targeting human epidermal growth factor receptor 2 (HER-2) with bystander effect. T-DXd can not only significantly improve the survival of HER-2-positive advanced breast cancer patients, but also enable advanced breast cancer patients with low HER-2 expression to benefit from HER-2-targeted therapy. T-DXd has been approved by the National Medical Products Administration (NMPA) for the treatment of HER-2-positive or HER-2-low breast cancer patients...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38643934/aicar-confers-prophylactic-cardioprotection-in-doxorubicin-induced-heart-failure-in-rats
#40
JOURNAL ARTICLE
Anurag Choksey, Ryan D Carter, Benjamin D Thackray, Vicky Ball, Brett W C Kennedy, Lea Hong Tuan Ha, Eshita Sharma, John Broxholme, Marcos Castro-Guarda, Michael P Murphy, Lisa C Heather, Damian J Tyler, Kerstin N Timm
Doxorubicin (DOX) is a widely used chemotherapeutic agent that can cause serious cardiotoxic side effects, leading to heart failure (HF). Impaired mitochondrial function is thought to be key factor driving progression into HF. We have previously shown in a rat model of DOX-HF that heart failure with reduced ejection fraction correlates with mitochondrial loss and dysfunction. Adenosine monophosphate-dependent kinase (AMPK) is a cellular energy sensor, regulating mitochondrial biogenesis and energy metabolism, including fatty acid oxidation...
April 19, 2024: Journal of Molecular and Cellular Cardiology
keyword
keyword
23063
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.